Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Issue title: Selected proceedings of the 12th European Conference on Clinical Hemorheology, 22‐26 June 2003, Sofia, Bulgaria
Article type: Research Article
Authors: Leach, J. Kent; ; | Patterson, Eugene | O'Rear, Edgar A.; ;
Affiliations: School of Chemical Engineering and Materials Science, University of Oklahoma, Norman, OK 73019, USA | University of Oklahoma Bioengineering Center, Norman, OK 73019, USA | University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA
Note: [] Current address: University of Michigan, Biologic & Materials Sciences, School of Dentistry, Room 5210, 1011 N. University Avenue, Ann Arbor, MI 48109, USA.
Note: [] Corresponding author: Prof. Edgar A. O'Rear, University of Oklahoma, 100 East Boyd, Room T‐335, Norman, OK 73019, USA. Tel.: +1 405 325 4379; Fax: +1 405 325 5813; E‐mail: eorear@ou.edu.
Abstract: Our efforts have focused on investigating the potential benefit of encapsulated thrombolytic agents for treatment of clot‐based crises. Liposome encapsulated plasminogen activators (LEPAs) have demonstrated improved thrombolysis in vivo in multiple laboratories. Compared to free agents, LEPAs demonstrate faster reperfusion times, reduced residual clot masses, and more rapid and complete restoration of blood flow. We have encapsulated streptokinase in both liposomes (LESK) and polymer microcapsules (MESK). Both formulations demonstrated reductions in reperfusion times, residual clot mass, and improved return of flow compared to identical dosages of free streptokinase in a thrombosed rabbit carotid, with MESK resulting in comparable or even greater improvements. In addition, marked reductions in bleeding complications and ventricular infarct size have been observed in a canine model of acute myocardial infarction. The mechanism for MESK has recently been explored in our laboratory using multiple microscopic techniques. MESK appears to resist adsorption to the leading edge of the thrombus, a common limitation for the permeation of free plasminogen activators. By avoiding adsorption and penetrating the thrombus, greater spatial distribution of the agent within the clot can be achieved. This data suggests that encapsulation of streptokinase could provide a therapeutic option for treatment of thrombosed arteries.
Journal: Clinical Hemorheology and Microcirculation, vol. 30, no. 3-4, pp. 225-228, 2004
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl